Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies.
Sign Up to like & getrecommendations! Published in 2021 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2021.09.024
Abstract: Over the past fifteen years, treatments using monoclonal antibodies specifically targeting cytokines have been developed to treat chronic inflammatory diseases, including rheumatoid arthritis or psoriasis, both associated with increased cardiovascular risk. The cardiovascular impact of… read more here.
Keywords: risk; targeting cytokines; monoclonal antibodies; treatment ... See more keywords
Targeting cytokines in inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2022 at "Science Translational Medicine"
DOI: 10.1126/scitranslmed.abq4473
Abstract: Targeting cytokines in inflammatory bowel disease (IBD) is a useful clinical approach. Potential therapies for IBD include regulatory T cell transfer to restore cytokine balance, blocking proinflammatory cytokines (e.g., IL-12 and IL-23) or their receptors… read more here.
Keywords: inflammatory bowel; bowel disease; targeting cytokines; cytokines inflammatory ... See more keywords
Targeting Cytokines for Morphine Tolerance: A Narrative Review
Sign Up to like & getrecommendations! Published in 2019 at "Current Neuropharmacology"
DOI: 10.2174/1570159x15666171128144441
Abstract: Background: Despite its various side effects, morphine has been widely used in clinics for decades due to its powerful analgesic effect. Morphine tolerance is one of the major side effects, hindering its long-term usage for… read more here.
Keywords: targeting cytokines; tolerance narrative; tolerance; cytokines morphine ... See more keywords